Patents by Inventor Dennis M. Fenton

Dennis M. Fenton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4966844
    Abstract: In processes for recovery of biologically active polypeptides from fermentation cultures of recombinant host organisms, cell death is frequently a prerequisite for isolation processing of the recombinant product outside the fermentation vessel. Disclosed are improved methods for effecting efficient host cell death inside the fermentation vessel through uniformly contacting host cells in culture with microbicidal concentrations of benzyl alcohol. Illustratively, E. coli, B. subtilis, and P. aeruginosa cultures are advantageously treated with from 0.5 to 10.0% (v/v) of benzyl alcohol in the absence of pH or temperature changes within the fermentor.
    Type: Grant
    Filed: September 3, 1985
    Date of Patent: October 30, 1990
    Assignee: Amgen
    Inventors: Michael J. Tallen, Dennis M. Fenton
  • Patent number: 4329429
    Abstract: A process for the release of lactase from yeast cells comprising contacting the cells with an alkyl alcohol or a dialkyl ketone, followed by extraction of the lactase in an aqueous solution at a pH in the range 5.5 to 8.0 is disclosed. Also disclosed is a process for the selective reduction of protease activity in lactase preparations comprising heating an aqueous solution of lactase containing protease impurities in the presence of glycerol. Lactase stability during the heating process can optionally be enhanced by addition of manganous ion.
    Type: Grant
    Filed: March 24, 1980
    Date of Patent: May 11, 1982
    Assignee: Pfizer Inc.
    Inventor: Dennis M. Fenton
  • Patent number: 4316960
    Abstract: A process for the preparation of 2,5-diketogluconic acid by the aerobic propagation of Acetobacter cerinus in a fermentation medium containing above about 20 and up to about 30% (wt/vol) glucose and at least about 0.04 wt. % choline based on the amount of glucose in the medium.
    Type: Grant
    Filed: April 10, 1980
    Date of Patent: February 23, 1982
    Assignee: Pfizer Inc.
    Inventors: Donald A. Kita, Dennis M. Fenton
  • Patent number: 4202942
    Abstract: 2-Ketogluconate present in a mixture with 2-ketogulonate is destroyed by fermentation with a strain of a Pseudomonas species leaving desired 2-ketogulonate intact. Subsequent hydrolysis of the 2-ketogulonate yields ascorbic acid.
    Type: Grant
    Filed: July 20, 1978
    Date of Patent: May 13, 1980
    Assignee: Pfizer Inc.
    Inventors: Donald A. Kita, John W. Gagne, Dennis M. Fenton